Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 748 entries
Sorted by: Best Match Show Resources per page
Retraction statement: Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation.

European journal of neurology

[No authors listed]
PMID: 24266049
Eur J Neurol. 2013 Nov;20(11):1497. doi: 10.1111/ene.12276.

No abstract available.

Cite
Retraction statement: Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation. Eur J Neurol. 2013;20(11):1497doi: 10.1111/ene.12276.
(2013). Retraction statement: Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation. European journal of neurology, 20(11), 1497. https://doi.org/10.1111/ene.12276
"Retraction statement: Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation." European journal of neurology vol. 20,11 (2013): 1497. doi: https://doi.org/10.1111/ene.12276
Retraction statement: Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation. Eur J Neurol. 2013 Nov;20(11):1497. doi: 10.1111/ene.12276. PMID: 24266049.
Copy Download .nbib Format: NLM
Response to the comment 'Conflicting evidence on the association of white matter hyperintensities with large-artery disease'.

European journal of neurology

Park JH, Ovbiagele B.
PMID: 26371442
Eur J Neurol. 2015 Oct;22(10):e81. doi: 10.1111/ene.12737.

No abstract available.

Cite
Park JH, Ovbiagele B. Response to the comment 'Conflicting evidence on the association of white matter hyperintensities with large-artery disease'. Eur J Neurol. 2015;22(10):e81doi: 10.1111/ene.12737.
Park, J. H., & Ovbiagele, B. (2015). Response to the comment 'Conflicting evidence on the association of white matter hyperintensities with large-artery disease'. European journal of neurology, 22(10), e81. https://doi.org/10.1111/ene.12737
Park, J-H, and Ovbiagele, B. "Response to the comment 'Conflicting evidence on the association of white matter hyperintensities with large-artery disease'." European journal of neurology vol. 22,10 (2015): e81. doi: https://doi.org/10.1111/ene.12737
Park JH, Ovbiagele B. Response to the comment 'Conflicting evidence on the association of white matter hyperintensities with large-artery disease'. Eur J Neurol. 2015 Oct;22(10):e81. doi: 10.1111/ene.12737. PMID: 26371442.
Copy Download .nbib Format: NLM
Electroclinical features of a patient with GLUT1 deficiency syndrome and adult onset periodic weakness.

European journal of neurology

Giliberto C, Reggio E, Sofia V, Giuliano L, Lo Fermo S, Barone R, Zappia M.
PMID: 26768679
Eur J Neurol. 2016 Jan;23(1):e1-3. doi: 10.1111/ene.12831.

No abstract available.

Cite
Giliberto C, Reggio E, Sofia V, et al. Electroclinical features of a patient with GLUT1 deficiency syndrome and adult onset periodic weakness. Eur J Neurol. 2016;23(1):e1-3doi: 10.1111/ene.12831.
Giliberto, C., Reggio, E., Sofia, V., Giuliano, L., Lo Fermo, S., Barone, R., & Zappia, M. (2016). Electroclinical features of a patient with GLUT1 deficiency syndrome and adult onset periodic weakness. European journal of neurology, 23(1), e1-3. https://doi.org/10.1111/ene.12831
Giliberto, C, et al. "Electroclinical features of a patient with GLUT1 deficiency syndrome and adult onset periodic weakness." European journal of neurology vol. 23,1 (2016): e1-3. doi: https://doi.org/10.1111/ene.12831
Giliberto C, Reggio E, Sofia V, Giuliano L, Lo Fermo S, Barone R, Zappia M. Electroclinical features of a patient with GLUT1 deficiency syndrome and adult onset periodic weakness. Eur J Neurol. 2016 Jan;23(1):e1-3. doi: 10.1111/ene.12831. PMID: 26768679.
Copy Download .nbib Format: NLM
European Association of Young Neurologists and Trainees in 2016: the year of changes and the introduction of the Residents and Research Fellows section of the European Academy of Neurology.

European journal of neurology

Papp V, Balicza P, Sauerbier A, Klingelhöfer L, Zis P, Gyorfi O, Macerollo A.
PMID: 27431026
Eur J Neurol. 2016 Aug;23(8):e49-51. doi: 10.1111/ene.13044.

No abstract available.

Cite
Papp V, Balicza P, Sauerbier A, et al. European Association of Young Neurologists and Trainees in 2016: the year of changes and the introduction of the Residents and Research Fellows section of the European Academy of Neurology. Eur J Neurol. 2016;23(8):e49-51doi: 10.1111/ene.13044.
Papp, V., Balicza, P., Sauerbier, A., Klingelhöfer, L., Zis, P., Gyorfi, O., & Macerollo, A. (2016). European Association of Young Neurologists and Trainees in 2016: the year of changes and the introduction of the Residents and Research Fellows section of the European Academy of Neurology. European journal of neurology, 23(8), e49-51. https://doi.org/10.1111/ene.13044
Papp, V, et al. "European Association of Young Neurologists and Trainees in 2016: the year of changes and the introduction of the Residents and Research Fellows section of the European Academy of Neurology." European journal of neurology vol. 23,8 (2016): e49-51. doi: https://doi.org/10.1111/ene.13044
Papp V, Balicza P, Sauerbier A, Klingelhöfer L, Zis P, Gyorfi O, Macerollo A. European Association of Young Neurologists and Trainees in 2016: the year of changes and the introduction of the Residents and Research Fellows section of the European Academy of Neurology. Eur J Neurol. 2016 Aug;23(8):e49-51. doi: 10.1111/ene.13044. PMID: 27431026.
Copy Download .nbib Format: NLM
Quantified electroencephalographic changes in Parkinson's disease with and without dementia.

European journal of neurology

Pozzi D, Petracchi M, Sabe L, Dancygier G, García H, Starkstein S.
PMID: 24283483
Eur J Neurol. 1994 Nov;1(2):147-52. doi: 10.1111/j.1468-1331.1994.tb00063.x.

We examined the presence of quantified electroencephalographic (qEEG) differences between Parkinson's disease (PD) patients with and without dementia, and a group of age-comparable normal controls. While there were no significant differences in relative power in any of the qEEG...

Cite
Pozzi D, Petracchi M, Sabe L, et al. Quantified electroencephalographic changes in Parkinson's disease with and without dementia. Eur J Neurol. 1994;1(2):147-52doi: 10.1111/j.1468-1331.1994.tb00063.x.
Pozzi, D., Petracchi, M., Sabe, L., Dancygier, G., García, H., & Starkstein, S. (1994). Quantified electroencephalographic changes in Parkinson's disease with and without dementia. European journal of neurology, 1(2), 147-52. https://doi.org/10.1111/j.1468-1331.1994.tb00063.x
Pozzi, D, et al. "Quantified electroencephalographic changes in Parkinson's disease with and without dementia." European journal of neurology vol. 1,2 (1994): 147-52. doi: https://doi.org/10.1111/j.1468-1331.1994.tb00063.x
Pozzi D, Petracchi M, Sabe L, Dancygier G, García H, Starkstein S. Quantified electroencephalographic changes in Parkinson's disease with and without dementia. Eur J Neurol. 1994 Nov;1(2):147-52. doi: 10.1111/j.1468-1331.1994.tb00063.x. PMID: 24283483.
Copy Download .nbib Format: NLM
Bilateral thalamic damage, cortical hypometabolism and behavioural disturbances.

European journal of neurology

de Falco FA, Soricelli A, Majello L, Modafferi A, Grossi D.
PMID: 24283486
Eur J Neurol. 1994 Nov;1(2):165-9. doi: 10.1111/j.1468-1331.1994.tb00066.x.

Thalamic damage could be responsible for reduced metabolism in anterior cortical areas. In order to investigate an anatomical lesion and impairment of regional blood flow (rCBF) in distant cortical areas, we studied by magnetic resonance imaging (MRI) and single...

Cite
de Falco FA, Soricelli A, Majello L, et al. Bilateral thalamic damage, cortical hypometabolism and behavioural disturbances. Eur J Neurol. 1994;1(2):165-9doi: 10.1111/j.1468-1331.1994.tb00066.x.
de Falco, F. A., Soricelli, A., Majello, L., Modafferi, A., & Grossi, D. (1994). Bilateral thalamic damage, cortical hypometabolism and behavioural disturbances. European journal of neurology, 1(2), 165-9. https://doi.org/10.1111/j.1468-1331.1994.tb00066.x
de Falco, F A, et al. "Bilateral thalamic damage, cortical hypometabolism and behavioural disturbances." European journal of neurology vol. 1,2 (1994): 165-9. doi: https://doi.org/10.1111/j.1468-1331.1994.tb00066.x
de Falco FA, Soricelli A, Majello L, Modafferi A, Grossi D. Bilateral thalamic damage, cortical hypometabolism and behavioural disturbances. Eur J Neurol. 1994 Nov;1(2):165-9. doi: 10.1111/j.1468-1331.1994.tb00066.x. PMID: 24283486.
Copy Download .nbib Format: NLM
Central motor conduction as a measure of disease progression in early multiple sclerosis.

European journal of neurology

Ravnborg M, Sørensen PS, Christiansen P, Blinkenberg M.
PMID: 24283524
Eur J Neurol. 1995 Jan;1(3):233-41. doi: 10.1111/j.1468-1331.1995.tb00077.x.

We monitored disease progression in 27 patients with clinically or laboratory-supported definite multiple sclerosis by means of clinical assessments [expanded disability status scale (EDSS), and the neurologic rating scale (NRS)] repeated at 6 month intervals for 2 years. Each...

Cite
Ravnborg M, Sørensen PS, Christiansen P, et al. Central motor conduction as a measure of disease progression in early multiple sclerosis. Eur J Neurol. 1995;1(3):233-41doi: 10.1111/j.1468-1331.1995.tb00077.x.
Ravnborg, M., Sørensen, P. S., Christiansen, P., & Blinkenberg, M. (1995). Central motor conduction as a measure of disease progression in early multiple sclerosis. European journal of neurology, 1(3), 233-41. https://doi.org/10.1111/j.1468-1331.1995.tb00077.x
Ravnborg, M, et al. "Central motor conduction as a measure of disease progression in early multiple sclerosis." European journal of neurology vol. 1,3 (1995): 233-41. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00077.x
Ravnborg M, Sørensen PS, Christiansen P, Blinkenberg M. Central motor conduction as a measure of disease progression in early multiple sclerosis. Eur J Neurol. 1995 Jan;1(3):233-41. doi: 10.1111/j.1468-1331.1995.tb00077.x. PMID: 24283524.
Copy Download .nbib Format: NLM
Peripheral iron metabolism in patients with focal cerebral ischemia.

European journal of neurology

Molina JA, Jiménez-Jiménez FJ, Ayuso-Peralta L, Cabrera-Valdivia F, Pérez-Sempere A, Egido JA, Soriano-Soriano C, Gómez-Lzquierdo MT, Muñoz-Rivero MC, Fernández-Calle P.
PMID: 24283609
Eur J Neurol. 1995 Apr;2(2):107-9. doi: 10.1111/j.1468-1331.1995.tb00101.x.

To ascertain the possible role of iron as a risk factor for cerebral ischemia, we studied the serum levels of iron, transferrin and ferritin in 42 patients between the third and seventh days after a cerebral ischemic event (transient...

Cite
Molina JA, Jiménez-Jiménez FJ, Ayuso-Peralta L, et al. Peripheral iron metabolism in patients with focal cerebral ischemia. Eur J Neurol. 1995;2(2):107-9doi: 10.1111/j.1468-1331.1995.tb00101.x.
Molina, J. A., Jiménez-Jiménez, F. J., Ayuso-Peralta, L., Cabrera-Valdivia, F., Pérez-Sempere, A., Egido, J. A., Soriano-Soriano, C., Gómez-Lzquierdo, M. T., Muñoz-Rivero, M. C., & Fernández-Calle, P. (1995). Peripheral iron metabolism in patients with focal cerebral ischemia. European journal of neurology, 2(2), 107-9. https://doi.org/10.1111/j.1468-1331.1995.tb00101.x
Molina, J A, et al. "Peripheral iron metabolism in patients with focal cerebral ischemia." European journal of neurology vol. 2,2 (1995): 107-9. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00101.x
Molina JA, Jiménez-Jiménez FJ, Ayuso-Peralta L, Cabrera-Valdivia F, Pérez-Sempere A, Egido JA, Soriano-Soriano C, Gómez-Lzquierdo MT, Muñoz-Rivero MC, Fernández-Calle P. Peripheral iron metabolism in patients with focal cerebral ischemia. Eur J Neurol. 1995 Apr;2(2):107-9. doi: 10.1111/j.1468-1331.1995.tb00101.x. PMID: 24283609.
Copy Download .nbib Format: NLM
Decreased serum selenium concentrations in patients with Parkinson's disease.

European journal of neurology

Jiménez-Jiménez FJ, Molina JA, Arrieta FJ, Aguilar MV, Cabrera-Valdivia F, Vázquez A, Jorge-Santamaría A, Seijas V, Fernández-Calle P, Martínez-Para MC.
PMID: 24283610
Eur J Neurol. 1995 Apr;2(2):111-4. doi: 10.1111/j.1468-1331.1995.tb00102.x.

Selenium is an essential component of the antioxidant enzyme glutathione peroxidase. The activity of this enzyme is reduced in the substantia nigra of patients with Parkinson's disease (PD), but the results of studies on erythrocytes are controversial. We compared...

Cite
Jiménez-Jiménez FJ, Molina JA, Arrieta FJ, et al. Decreased serum selenium concentrations in patients with Parkinson's disease. Eur J Neurol. 1995;2(2):111-4doi: 10.1111/j.1468-1331.1995.tb00102.x.
Jiménez-Jiménez, F. J., Molina, J. A., Arrieta, F. J., Aguilar, M. V., Cabrera-Valdivia, F., Vázquez, A., Jorge-Santamaría, A., Seijas, V., Fernández-Calle, P., & Martínez-Para, M. C. (1995). Decreased serum selenium concentrations in patients with Parkinson's disease. European journal of neurology, 2(2), 111-4. https://doi.org/10.1111/j.1468-1331.1995.tb00102.x
Jiménez-Jiménez, F J, et al. "Decreased serum selenium concentrations in patients with Parkinson's disease." European journal of neurology vol. 2,2 (1995): 111-4. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00102.x
Jiménez-Jiménez FJ, Molina JA, Arrieta FJ, Aguilar MV, Cabrera-Valdivia F, Vázquez A, Jorge-Santamaría A, Seijas V, Fernández-Calle P, Martínez-Para MC. Decreased serum selenium concentrations in patients with Parkinson's disease. Eur J Neurol. 1995 Apr;2(2):111-4. doi: 10.1111/j.1468-1331.1995.tb00102.x. PMID: 24283610.
Copy Download .nbib Format: NLM
Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up.

European journal of neurology

Ghezzi A, Zaffaroni M, Filippi M, Reganati P, Zibetti A.
PMID: 24283615
Eur J Neurol. 1995 Apr;2(2):139-41. doi: 10.1111/j.1468-1331.1995.tb00107.x.

Seventeen chronic progressive multiple sclerosis patients were treated with natural interferon-beta (IFN-β) for 2 years, thereafter they were followed up for 2 years. IFN-β was given 1 million IU/day i.m. for 1 week, then 3 million IU daily for...

Cite
Ghezzi A, Zaffaroni M, Filippi M, et al. Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up. Eur J Neurol. 1995;2(2):139-41doi: 10.1111/j.1468-1331.1995.tb00107.x.
Ghezzi, A., Zaffaroni, M., Filippi, M., Reganati, P., & Zibetti, A. (1995). Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up. European journal of neurology, 2(2), 139-41. https://doi.org/10.1111/j.1468-1331.1995.tb00107.x
Ghezzi, A, et al. "Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up." European journal of neurology vol. 2,2 (1995): 139-41. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00107.x
Ghezzi A, Zaffaroni M, Filippi M, Reganati P, Zibetti A. Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up. Eur J Neurol. 1995 Apr;2(2):139-41. doi: 10.1111/j.1468-1331.1995.tb00107.x. PMID: 24283615.
Copy Download .nbib Format: NLM
Oromandibular dystonia associated with fluoxetine.

European journal of neurology

Segovia JG, Alvarez-Cermeño JC.
PMID: 24283616
Eur J Neurol. 1995 Apr;2(2):143-4. doi: 10.1111/j.1468-1331.1995.tb00108.x.

A 66 year old patient with major depression treated with fluoxetine developed persistent oromandibular dystonia and mild akathisia. She improved significantly after discontinuation of the drug and treatment with biperiden. The temporal relationship between the use of fluoxetine and...

Cite
Segovia JG, Alvarez-Cermeño JC. Oromandibular dystonia associated with fluoxetine. Eur J Neurol. 1995;2(2):143-4doi: 10.1111/j.1468-1331.1995.tb00108.x.
Segovia, J. G., & Alvarez-Cermeño, J. C. (1995). Oromandibular dystonia associated with fluoxetine. European journal of neurology, 2(2), 143-4. https://doi.org/10.1111/j.1468-1331.1995.tb00108.x
Segovia, J G, and Alvarez-Cermeño, J C. "Oromandibular dystonia associated with fluoxetine." European journal of neurology vol. 2,2 (1995): 143-4. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00108.x
Segovia JG, Alvarez-Cermeño JC. Oromandibular dystonia associated with fluoxetine. Eur J Neurol. 1995 Apr;2(2):143-4. doi: 10.1111/j.1468-1331.1995.tb00108.x. PMID: 24283616.
Copy Download .nbib Format: NLM
Subcortical aphasia: a specific clinical picture?.

European journal of neurology

Demeurisse G, de Beuckelaer R, Derouck M, Capon AP.
PMID: 24283682
Eur J Neurol. 1995 Sep;2(4):317-23. doi: 10.1111/j.1468-1331.1995.tb00133.x.

100 aphasic patients were examined with a scorable aphasia battery looking at the frequency of various aphasia types and the possible specificity of clinical pictures in deep-seated lesions. One month after onset, "atypical" aphasiological syndromes proved to be rare...

Cite
Demeurisse G, de Beuckelaer R, Derouck M, et al. Subcortical aphasia: a specific clinical picture?. Eur J Neurol. 1995;2(4):317-23doi: 10.1111/j.1468-1331.1995.tb00133.x.
Demeurisse, G., de Beuckelaer, R., Derouck, M., & Capon, A. P. (1995). Subcortical aphasia: a specific clinical picture?. European journal of neurology, 2(4), 317-23. https://doi.org/10.1111/j.1468-1331.1995.tb00133.x
Demeurisse, G, et al. "Subcortical aphasia: a specific clinical picture?." European journal of neurology vol. 2,4 (1995): 317-23. doi: https://doi.org/10.1111/j.1468-1331.1995.tb00133.x
Demeurisse G, de Beuckelaer R, Derouck M, Capon AP. Subcortical aphasia: a specific clinical picture?. Eur J Neurol. 1995 Sep;2(4):317-23. doi: 10.1111/j.1468-1331.1995.tb00133.x. PMID: 24283682.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 748 entries